A Randomized, 6-week, Placebo-Controlled Study of Treatment for Adult Attention-Deficit Disorder: Individualized Dosing of Osmotic-Release Oral System (OROS) Methylphenidate With a Goal of Symptom Remission - Adult ADD ADHD Center of Maryland Internationally Recognized Expertise

A Randomized, 6-week, Placebo-Controlled Study of Treatment for Adult Attention-Deficit Disorder: Individualized Dosing of Osmotic-Release Oral System (OROS) Methylphenidate With a Goal of Symptom Remission

A Randomized, 6-week, Placebo-Controlled Study of Treatment for Adult Attention-Deficit Disorder: Individualized Dosing of Osmotic-Release Oral System (OROS) Methylphenidate With a Goal of Symptom Remission

Goodman DW, Starr LH, Yi-Wen M, Rostain AL, Ascher S. Armstron RB. J ClinPsychiatry 2017;78(1):105-114.

click to read abstract

March 1, 2017 / Professional Research Publications / Tags: adult ADD, adult ADD treatment, adult ADHD, adult ADHD treatment, Adult Attention Deficit Disorder, Adult Attention Deficit Hyperactivity Disorder, David W. Goodman MD, Goodman David MD, Treatment for ADD, Treatment for ADHD, Treatment for Adult Attention Hyperactivity Disorder, Treatment for Adult Attention-Deficit Disorder